Company Information
Company Profile
Cash Flow Statement
Profit & Loss
Financial Position
Financial Ratio
Industry 批发和零售业
Company Introduction 合肥立方制药股份有限公司成立于2002年，是集药品制剂及原料药的研发、生产、销售，药品与医疗器械的批发、零售于一体的创新型医药企业，对医药工业及医药商业形成全产业链覆盖，主要工业产品涉及心血管类用药、消化系统用药、皮肤外用药、内分泌系统用药等领域。立方股份拥有4家工业企业、1家医药商业企业和1家药品零售连锁企业，共有员工800余人。目前公司已获得25项发明专利，并先后取得“国家火炬计划重点高新技术企业”、“安徽省创新型企业”、“省认定企业技术中心”、“中国医药工业最具投资价值企业”、“安徽省专精特新中小企业”、“安徽省药物缓释工程技术中心”、“合肥市知识产权示范企业”等荣誉；公司工业和商业企业均是“安徽省医药质量奖”、“双优奖”获得者、安徽省A级纳税企业，安徽省守合同重信用单位；公司建有安徽省博士后科研工作站，是安徽省医药行业协会法人单位、中国化学制药工业协会副会长单位。立方股份坚持“创新是企业最高效率”的理念，建立了由配方技术、制剂评价技术、制剂工程化技术以及关键设备技术四大部分组成的渗透泵控释技术平台，并不断提升渗透泵制剂产品开发与产业化能力，主要产品包括非洛地平缓释片（Ⅱ）、甲磺酸多沙唑嗪缓释片等。 立方股份建有片剂、颗粒剂、胶囊剂、软膏剂、凝胶剂、原料药、口服溶液剂、中药提取等12条GMP生产线，拥有药品注册批件109项。生产销售的主要产品包括非洛地平缓释片（II）、甲磺酸多沙唑嗪缓释片、二甲双胍格列吡嗪片、亮菌口服溶液、益气和胃胶囊、坤宁颗粒、复方土荆皮凝胶、丹皮酚软膏等，覆盖心血管、糖尿病、消化、泌尿、妇科、皮肤外用药等多个临床领域。 经过数十年的精心打造，公司建立了一支专业的、富有创新力和共同价值观的优秀管理团队，团队成员均来自行业的研发、技术、生产、营销体系，在公司成立后一直从事相关工作，积累了丰富的从业经验，对医药行业的现状与未来有着独到的见解。公司及各子公司、各细分领域都拥有该细分行业领域的专业从业人员，为公司的稳健运营奠定了坚实的基础，也是公司持续发展壮大的中坚力量。 公司开创了“引进、培养、合作”的人才战略。根据公司发展的战略需要引进国内外高端技术人才，担任研发各学科带头人，已引进人才包括新型给药技术、生物抗体工程、化学合成及杂质分析与控制等技术领域；采用帮带和梯度培养模式，在研究工作实践过程中进行人才培养，完善激励创新政策，建立研发人员成长发展通道；通过外聘等多种方式，与需求领域专家建立长期稳定的合作关系，直接参与和指导本企业研发，有效利用外部人才资源。 立方股份秉承“为人以诚、为事以专”的经营宗旨，积极倡导“以效率为核心”的企业文化。 立方股份将发挥全体员工的智慧，务实创新，加快发展，用过硬的产品与服务，与供应商、分销商、医院和零售终端等合作伙伴精诚合作，同心缔造利益共同体，谱写立方股份更加灿烂辉煌的新篇章，为人类健康事业做出更大贡献。
Main Business 药品侧剂及原料药的研发、生产、销售，药品与医疗器械的批发、零售。
Legal Representative 季俊虬
Top Executives
董事长：季俊虬
副董事长：邓晓娟
董事：王清,陈军,高美华,邓晓娟
独立董事：杨模荣,李进华,史静
Top 5 Shareholder
Shareholder name Nature Holding Date
季俊虬限售股+流通A股27.05%30/09/2024
合肥立方投资集团有限公司流通A股19.56%30/09/2024
邓晓娟限售股+流通A股6.99%30/09/2024
高美华流通A股3.36%30/09/2024
招商银行股份有限公司－东方红睿泽三年持有期混合型证券投资基金流通A股2.51%30/09/2024
Company Secretary 夏军
Solicitors 北京市竞天公诚律师事务所
Auditors 中汇会计师事务所（特殊普通合伙）
Tel No 0551-65350370
Fax No 0551-65350370
Website www.lifeon.cn
Email zqb@lifeon.cn
Company Address
Register: 安徽省合肥市长江西路669号立方厂区
Office: 安徽省合肥市长江西路669号立方厂区
Listing Date 15/12/2020
Shares Capital
Shares Capital: 191,571,763
Total A Share: 191,571,763
Listed A Share: 138,164,876
Non-tradable A Share: 53,406,887
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 1.420
DPS(RMB)* ¥ 0.500
NBV Per Share(RMB)* ¥ 10.556
Market Capitalization(RMB) 2.517B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Chiyu Banking Corporation Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.